Recent News
November 09, 2018 Aduro Biotech Presents Preliminary Results from Ongoing Phase 1 Trials of STING agonist ADU-S100 (MIW815) in Patients with Advanced Solid Tumors or Lymphomas
November 06, 2018 Aduro to Host and Webcast an Investor Event to Review Data Presented at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 30, 2018 Aduro Biotech Reports Third Quarter 2018 Financial Results
Careers
Are you interested in working for a company where interactions are authentic, commitment is high and people excel together?
